Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | CCND3 |
| Upstream (Parents) |
|---|
| (<<) BCL2 → CCND3 |
| (<<) CORO1A → CCND3 |
| (<<) FUT11 → CCND3 |
| (<<) GPNMB → CCND3 |
| (<<) GPX2 → CCND3 |
| (<<) GRHPR → CCND3 |
| (<<) HIF1A → CCND3 |
| (<<) KRAS → CCND3 |
| (<<) LTB → CCND3 |
| (<<) MAL → CCND3 |
| (<<) MAPK6 → CCND3 |
| (<<) MPHOSPH6 → CCND3 |
| (<<) MYO10 → CCND3 |
| (<<) PABPC3 → CCND3 |
| (<<) PLA2G12A → CCND3 |
| (<<) PPP1R11 → CCND3 |
| (<<) PTMA → CCND3 |
| (<<) SPAG5 → CCND3 |
| (<<) ST3GAL2 → CCND3 |
| (<<) STK16 → CCND3 |
| (<<) TRERF1 → CCND3 |
| (<<) UCN2 → CCND3 |
| (<<) YWHAG → CCND3 |
| (<<) ZFP36 → CCND3 |
| Downstream (Children) |
|---|
| CCND3 → ERP27 (>>) |
| CCND3 → HSPA2 (>>) |
| CCND3 → PIK3C3 (>>) |
